Air Fluzal For Spiro 250

Adult dosage

Adults with asthma and children aged 12 years and older: Administer salmeterol 50 μg + fluticasone propionate 100 μg via metered-dose inhalation twice daily, or salmeterol 50 μg + fluticasone propionate 250 μg twice daily, or salmeterol 50 μg + fluticasone propionate 500 μg twice daily. Adults with chronic obstructive pulmonary disease: Salmeterol 50 μg + fluticasone propionate 250 μg.

Children's dosage

Children aged 4 to 11 years: Administer salmeterol 50 μg + fluticasone propionate 100 μg via metered-dose inhalation twice daily. There are no useful data for the use of this medication in children under 4 years of age.

This medication takes about 10 to 20 minutes to show bronchodilator effects, and should not be used in patients with acute asthma attacks or life-threatening severe asthma exacerbation. For the treatment of acute asthma attacks, a fast-acting inhaler should be used instead of this medication, and patients should be educated to always carry it with them. Do not administer to patients with hypersensitivity to this medication, patients with cardiac arrhythmias, untreated respiratory infection, or severe bronchiectasis. Patients with a history of cardiovascular disease or conditions such as diabetes, hyperthyroidism, or seizure disorders should use this medication with caution. This medication can cause serious side effects such as paradoxical bronchospasm after inhalation, so if symptoms occur, use should be discontinued immediately and a doctor should be consulted. Major side effects include palpitations, headache, nausea, muscle pain, hoarseness, and oral candidiasis, and it is advisable to rinse the mouth after inhalation. This medication can interact with other drugs, so caution is necessary, especially when used in conjunction with beta-blockers, CYP3A4 inhibitors, and steroid medications. During pregnancy, it should only be used at the minimum effective dose to minimize risk to the fetus, and during breastfeeding, it should be used after consulting a healthcare professional. The safety and effectiveness of this medication have not been established in children under 4 years of age, and caution should be taken in pediatric and adolescent patients as long-term high-dose use may result in growth retardation. In the elderly, there is a risk of cardiovascular adverse reactions, so it should be administered with careful observation. In case of overdose, serious symptoms such as arrhythmias, blood pressure changes, and hypokalemia may occur, requiring immediate medical treatment. This medication is intended for oral inhalation only, and after use, patients should rinse their mouth to prevent oral candidiasis. If asthma symptoms worsen during treatment or the use of fast-acting inhalers increases, a doctor's assessment should be sought immediately, and discontinuation of use should not be done arbitrarily. This medication should be kept out of reach of children and stored in a cool place.

Serious side effects

Hives, severe swelling (edema), choking, bronchospasm, angioedema, anaphylactic reactions (severe allergic reactions), shortness of breath, wheezing, difficulty breathing, chest tightness, severe rash accompanied by high fever, blisters, skin detachment, pain in mucous membranes of mouth/eyes (severe skin adverse reactions), yellowing of skin or eyes (jaundice), severe swelling, noticeable decrease in urine output, edema accompanied by high blood pressure, sudden and very severe

Mild side effects

• Viral gastroenteritis
• nausea
• vomiting
• diarrhea
• abdominal pain
• palpitations
• headache
• tremors
• tachycardia
• atrial fibrillation

This medication is sensitive to light; therefore, it should be stored in a container that protects it from light. Additionally, it is important to store it at a cool temperature below 25 degrees to maintain its efficacy.

Appearance

A metered-dose inhaler with a blister strip filled with a uniform white powder, mounted in a plastic container.

Package unit

60 doses / 1 container